Papers associated with diencephalon (and magainins)

Limit to papers also referencing gene:
Show all diencephalon papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Investigating specific bacterial resistance to AMPs by using a magainin I-resistant Escherichia coli model., de Almeida KC., J Antibiot (Tokyo). October 1, 2014; 67 (10): 681-7.
	Peptidomic analysis of skin secretions provides insight into the taxonomic status of the African clawed frogs Xenopus victorianus and Xenopus laevis sudanensis (Pipidae)., King JD., Comp Biochem Physiol Part D Genomics Proteomics. September 1, 2013; 8 (3): 250-4.
	A hybrid peptide derived from cecropin-A and magainin-2 inhibits osteoclast differentiation., Kwak HB., Life Sci. July 11, 2003; 73 (8): 993-1005.
	The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm., Haukland HH., FEBS Lett. November 23, 2001; 508 (3): 389-93.
	Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures., Oh D., Biochemistry. October 3, 2000; 39 (39): 11855-64.
	Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria., Giacometti A., Peptides. August 1, 2000; 21 (8): 1155-60.
	In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia., Giacometti A., Antimicrob Agents Chemother. June 1, 2000; 44 (6): 1716-9.
	In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically., Giacometti A., Antimicrob Agents Chemother. June 1, 2000; 44 (6): 1694-6.
	In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa., Giacometti A., J Antimicrob Chemother. November 1, 1999; 44 (5): 641-5.
	Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli., Vorland LH., Scand J Infect Dis. January 1, 1999; 31 (5): 467-73.
	In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria., Giacometti A., Antimicrob Agents Chemother. December 1, 1998; 42 (12): 3320-4.
	In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii., Cirioni O., J Antimicrob Chemother. October 1, 1998; 42 (4): 445-51.
	In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis carinii., Cirioni O., J Antimicrob Chemother. August 1, 1998; 42 (2): 141-5.
	Killing of Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia by protegrins., Miyasaki KT., J Periodontal Res. February 1, 1998; 33 (2): 91-8.
	Differentiation-associated antimicrobial functions in human colon adenocarcinoma cell lines., Bernet-Camard MF., Exp Cell Res. July 10, 1996; 226 (1): 80-9.
	Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import., Hugosson M., Eur J Biochem. August 1, 1994; 223 (3): 1027-33.
	Resistance to host antimicrobial peptides is necessary for Salmonella virulence., Groisman EA., Proc Natl Acad Sci U S A. December 15, 1992; 89 (24): 11939-43.

???pagination.result.page??? 1